Nancy McKinstry - 24 Feb 2022 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
Director
Signature
/s/ Nancy McKinstry by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
24 Feb 2022
Transactions value $
-$516
Form type
4
Filing time
25 Feb 2022, 16:23:55 UTC
Previous filing
17 Feb 2022
Next filing
03 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $187K +6.28K +23.14% $29.84 33.4K 24 Feb 2022 Direct
transaction ABT Common shares without par value Sale -$188K -1.61K -4.83% $116.43 31.8K 24 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -6.28K -100% $0.00* 0 24 Feb 2022 Common Shares 6.28K $29.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.